Specific cell-to-cell communication associated with progression of gastrointestinal stromal tumors – News-Medical.Net

Gastrointestinal stromal tumors (GISTs) are a subytpe of cancers known as sarcomas. GIST is the most common type of sarcoma with approximately 5,000 to 6,000 new patient cases annually in the United States. GIST cannot be cured by drugs alone, and targeted therapies are only modestly effective, with a high rate of drug resistance. In a recent study, researchers at University of California San Diego School of Medicine identified new therapeutic targets that could lead to new treatment options for…

Click here to view the original article.